Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea
· Delayed Price · Currency is KRW 21,900
-100 (-0.45%)
Apr 29, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 987.53 billion as of April 29, 2026. Its market cap has increased by 251.06% in one year.
Market Cap
987.53B
Enterprise Value
934.92B
Revenue
53.39B
Ranking
n/a
PE Ratio
62.57
Stock Price
21,900.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 987.53B, an increase of 428.35%. That is a compound annual growth rate of 241.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 987.53B | 13.54% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GI Innovation | 1,029.08B |
| MEDIPOST | 1,033.81B |
| Pharmicell | 1,096.87B |
| Medy-Tox | 705.99B |
| Proteina | 696.84B |
| GC Corp. | 653.33B |
| Chabiotech | 1,659.44B |
| Orum Therapeutics | 1,789.89B |